Cargando…
Implementation Study of Patient-Ready Syringes Containing 25 mg/mL Methotrexate Solution for Use in Treating Ectopic Pregnancy
Background. Ectopic pregnancy (EP) is a significant cause of morbidity and mortality during the first trimester of pregnancy. Small unruptured tubal pregnancies can be treated medically with a single dose of methotrexate (MTX). Objective. The aim of this study was to evaluate the stability of a 25 m...
Autores principales: | Respaud, R., Gaudy, A. S., Arlicot, C., Tournamille, J. F., Viaud-Massuard, M. C., Elfakir, C., Antier, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037123/ https://www.ncbi.nlm.nih.gov/pubmed/24900977 http://dx.doi.org/10.1155/2014/689308 |
Ejemplares similares
-
T-piece made from a 10 ml syringe
por: Shahid, Razi, et al.
Publicado: (2020) -
Iodine-125 seed implantation treatment of lung metastases < 2.5 cm using 5-ml syringe as a guide
por: Li, Jie, et al.
Publicado: (2020) -
The Lynch Aseptic Syringe Container
Publicado: (1903) -
Methotrexate for Cornual Ectopic Pregnancy
por: Parker, Barbara M, et al.
Publicado: (2020) -
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT‐P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects
por: Davidson, Antonia, et al.
Publicado: (2021)